icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
Effectiveness of 8 vs. 12 Week Ledipasvir/Sofosbuvir (LDV/SOF) in Black, Treatment Na´ve Patients with Non-Cirrhotic, Genotype 1 HCV and Baseline Viral Load: Analyses of Real-World Data from the TRIO Network
 
 
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
 
MICHAEL CURRY1, BRUCE BACON2 ,STEVEN FLAMM3, ANGELA LANDEN4, SCOTT MILLIGAN4, NAOKY TSAI5, ZOBAIR YOUNOSSI6 AND NEZAM AFDHAL1
1Beth Israel Deaconess Medical Center, 2Saint Louis University School of Medicine, 3Northwestern University Medical School, 4Trio Health Analytics, 5University of Hawaii; Queens Medical Center, 6Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital

AASDL1

AASDL2

AASDL3